Recombinant dimeric small immunoproteins neutralize transmissible gastroenteritis virus infectivity efficiently in vitro and confer passive immunity in vivo
Small immunoproteins (SIPs) are single-chain molecules comprising the variable regions of an antibody assembled in a single polypeptide (scFv) and joined to the immunoglobulin heavy-chain dimerizing domain. To investigate the potential of these molecules to provide protection against enteric infections when supplied orally, SIPs were generated against Transmissible gastroenteritis virus (TGEV), a highly pathogenic porcine virus. Different variants of TGEV-specific SIPs were created, of ε and α isotypes, by exploiting the dimerizing domains εCH4 and αCH3 of human and swine origin. Transfected cells secreted these recombinant mini-antibodies efficiently, mainly as dimers stabilized covalently by inter-chain disulphide bridges. The specificity and functionality of the recombinant TGEV-specific SIPs were determined by in vitro binding, neutralization and infection-interference assays. The neutralization indices of the TGEV-specific SIPs were all very similar to that of the original TGEV-specific mAb, thus confirming that the immunological properties have been preserved in the recombinant SIPs. In vivo protection experiments on newborn piglets have, in addition, demonstrated a strong reduction of virus titre in infected tissues of animals treated orally with TGEV-specific SIPs. It has therefore been demonstrated that it is possible to confer passive immunization to newborn pigs by feeding them with recombinant SIPs.
AlamilloJ. M.,
MongerW.,
SolaI.,
GarciaB.,
PerrinY.,
BestagnoM.,
BurroneO. R.,
SabellaP.,
Plana-DuranJ.other authors2006; Use of virus vectors for the expression in plants of active full-length and single chain anti-coronavirus antibodies. Biotechnol J 1:1103–1111[CrossRef]
BatistaF. D.,
EfremovD. G.,
BurroneO. R.1996; Characterization of a second secreted IgE isoform and identification of an asymmetric pathway of IgE assembly. Proc Natl Acad Sci U S A 93:3399–3404[CrossRef]
BorsiL.,
BalzaE.,
BestagnoM.,
CastellaniP.,
CarnemollaB.,
BiroA.,
LepriniA.,
Sepulveda.J.,
BurroneO.other authors2002; Selective targeting of tumoral vasculature: comparison of different formats of an antibody (L19) to the ED-B domain of fibronectin. Int J Cancer 102:75–85[CrossRef]
CorreaI.,
JiménezG.,
SuñéC.,
BullidoM. J.,
EnjuanesL.1988; Antigenic structure of the E2 glycoprotein from transmissible gastroenteritis coronavirus. Virus Res 10:77–93[CrossRef]
CorreaI.,
GebauerF.,
BullidoM. J.,
SuñéC.,
BaayM. F.,
ZwaagstraK. A.,
PosthumusW. P. A.,
LenstraJ. A.,
EnjuanesL.1990; Localization of antigenic sites of the E2 glycoprotein of transmissible gastroenteritis coronavirus. J Gen Virol 71:271–279[CrossRef]
DelmasB.,
GelfiJ.,
L'HaridonR.,
VogelL. K.,
SjöströmH.,
NorenO.,
LaudeH.1992; Aminopeptidase N is a major receptor for the entero-pathogenic coronavirus TGEV. Nature 357:417–420[CrossRef]
EnjuanesL.,
Van der ZeijstB. A. M.1995; Molecular basis of transmissible gastroenteritis virus epidemiology. In The Coronaviridae pp 337–376 Edited by
SiddellS. G.
New York: Plenum Press;
EscorsD.,
CamafeitaE.,
OrtegoJ.,
LaudeH.,
EnjuanesL.2001; Organization of two transmissible gastroenteritis coronavirus membrane protein topologies within the virion and core. J Virol 75:12228–12240[CrossRef]
GebauerF.,
PosthumusW. P. A.,
CorreaI.,
SuñéC.,
SmerdouC.,
SánchezC. M.,
LenstraJ. A.,
MeloenR. H.,
EnjuanesL.1991; Residues involved in the antigenic sites of transmissible gastroenteritis coronavirus S glycoprotein. Virology 183:225–238[CrossRef]
HuS.,
ShivelyL.,
RaubitschekA.,
ShermanM.,
WilliamsL. E.,
WongJ. Y.,
ShivelyJ. E.,
WuA. M.1996; Minibody: a novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts. Cancer Res 56:3055–3061
LiE.,
PedrazaA.,
BestagnoM.,
MancardiS.,
SanchezR.,
BurroneO.1997; Mammalian cell expression of dimeric small immune proteins (SIP). Protein Eng 10:731–736[CrossRef]
OcchinoM.,
RaffaghelloL.,
BurroneO.,
GambiniC.,
PistoiaV.,
CorriasM. V.,
BestagnoM.2004; Generation and characterization of dimeric small immunoproteins specific for neuroblastoma associated antigen GD2. Int J Mol Med 14:383–388
SánchezC. M.,
JiménezG.,
LaviadaM. D.,
CorreaI.,
SuñéC.,
BullidoM.,
GebauerF.,
SmerdouC.,
CallebautP.other authors1990; Antigenic homology among coronaviruses related to transmissible gastroenteritis virus. Virology 174:410–417[CrossRef]
SánchezC. M.,
IzetaA.,
Sánchez-MorgadoJ. M.,
AlonsoS.,
SolaI.,
BalaschM.,
Plana-DuranJ.,
EnjuanesL.1999; Targeted recombination demonstrates that the spike gene of transmissible gastroenteritis coronavirus is a determinant of its enteric tropism and virulence. J Virol 73:7607–7618
Recombinant dimeric small immunoproteins neutralize transmissible gastroenteritis virus infectivity efficiently in vitro and confer passive immunity in vivo